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Note 
Slowing Antibiotic Resistance by Decreasing 
Antibiotic Use in Animals 
Jennifer Nomura* 
While antibiotics were originally developed for human use, 
veterinarians eventually began using them in animals, hoping 
the drugs would perform in animals the same way they did in 
humans.1 Approximately sixty percent of the diseases that 
humans get originate from animals,2 so veterinarians hoped 
that by giving animals antibiotics, the spread of disease would 
lessen.3 Today, antibiotics are mainly used in farm animals for 
both health reasons and animal growth purposes.4 Antibiotics 
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 1. See, e.g., Barbara O’Brien, Animal Welfare Reform and the Magic 
Bullet: The Use and Abuse of Subtherapeutic Doses of Antibiotics in Livestock, 
67 U. COLO. L. REV. 407, 422 (1996) (noting that use of antibiotics in animals 
“began after veterinarians experimented with administering antibiotics to sick 
animals to determine if the miracle drugs that save so many human lives 
could also help livestock”). 
 2. COLO. DEP’T OF AGRIC., ZOONOTIC DISEASE ADDENDUM 1 (2011), 
available at http://www.colorado.gov/cs/Satellite?blobcol=urldata&blobheader=
application%2Fpdf&blobkey=id&blobtable=MungoBlobs&blobwhere=1251690
810562&ssbinary=true. 
 3. See Animal Antibiotics and Food Safety: What You Should Know, 
FOOD INSIGHT (July 18, 2012), http://www.foodinsight.org/Resources/
Detail.aspx?topic=Animal_Antibiotics_and_Food_Safety_What_you_Should_K
now; see also Browse by Disease, CENTERS FOR DISEASE CONTROL & 
PREVENTION, http://www.cdc.gov/healthypets/browse_by_diseases.htm (last 
updated Sept. 28, 2012) (listing the diseases that are known to pass from 
animals to humans). 
 4. See, e.g., KENNETH H. MATHEWS, JR., U.S. DEP’T OF AGRIC., 
ANTIMICROBIAL DRUG USE AND VETERINARY COSTS IN U.S. LIVESTOCK 
PRODUCTION 3 (2001), available at http://www.ers.usda.gov/media/480677/
aib766_1_.pdf; Herbert S. Goldberg, Veterinary Medical and Nonmedical Uses 
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are typically given to animals either through their feed5 or 
water supply.6 The use of antibiotics in farm animals occurs 
most often in pork and poultry.7 Because farmers have been 
feeding antibiotics to animals for so many years, animals are 
becoming resistant to the effects of these drugs.8 Farmers want 
to continue to profit from the effects of antibiotics and have 
increased the amount of antibiotics given to animals to counter 
the effect of resistance.9 Today, animal consumption of 
antibiotics accounts for almost half of total antibiotic use in the 
United States.10 
                                                          
of Antibiotics, 22 FOOD DRUG COSM. L.J. 33, 34 (1967) (listing some of the 
benefits of antibiotics being used in animals, which includes animal survival 
and growth rate); Vanessa K.S. Briceño, Note, Superbug Me: The FDA’s Role 
in the Fight Against Antibiotic Resistance, 9 N.Y.U. J. LEGIS. & PUB. POL’Y 
521, 523 (2005) (discussing how antibiotics are used in animals to promote 
growth and prevent disease); Steve Mirsky, Animal Production Practices 
Create Antibiotic Resistance, SCI. AM. (Oct. 20, 2011), 
http://www.scientificamerican.com/podcast/episode.cfm?id=animal-production-
practices-create-11-10-20; Is Your Meat Safe? Antibiotic Debate Overview, 
PBS, http://www.pbs.org/wgbh/pages/frontline/shows/meat/safe/overview.html 
(last visited Sept. 5, 2013); see also Goldberg, supra, at 34 (discussing how 
antibiotics are helpful for weak and runt animals); O’Brien, supra note 1, at 
422 (discussing how antibiotics are mainly used to promote an animal’s 
growth rate). 
 5. See, e.g., Ariele Lessing, Killing Us Softly: How Sub-therapeutic 
Dosing of Livestock Causes Drug-Resistant Bacteria in Humans, 37 B.C. 
ENVTL. AFF. L. REV. 463, 470 (2010) (“[A]ntibiotics are administered 
preemptively to all confined animals in drug-laced feed . . . .”); O’Brien, supra 
note 1, at 422 (discussing how farmers feed their animals antibiotic-laced 
feed). 
 6. Robyn L. Goforth & Carol R. Goforth, Appropriate Regulation of 
Antibiotics in Livestock Feed, 28 B.C. ENVTL. AFF. L. REV. 39, 50 (2000). 
 7. Terence J. Centner, Regulating the Use of Non-Therapeutic Antibiotics 
in Food Animals, 21 GEO. INT’L ENVTL. L. REV. 1, 19 (2008) (“In the United 
States, the greatest quantities of non-therapeutic antibiotics are used for 
swine and poultry production.”). 
 8. See O’Brien, supra note 1, at 423; cf. Goforth & Goforth, supra note 6, 
at 51 (“[T]here is a general consensus among scientists that subtherapeutic 
doses of antibiotics used in animal feed favors the selection of antibiotic-
resistant bacteria.”). 
 9. See, e.g., Goforth & Goforth, supra note 6, at 46–47; O’Brien, supra 
note 1, at 423 (“Over time, farmers have had to increase gradually the 
amounts of antibiotics fed to the animals to maintain the same rate of growth 
per pound of laced feed.”). 
 10. See Lessing, supra note 5, at 469 (estimating seventy percent of all 
antibiotics in the United States are used in animals); Briceño, supra note 4, at 
524 (estimating that the antibiotic use in animals accounts for thirty-five to 
eighty-five percent of all antibiotic use); Edwin Dobb, Growing Resistance, 
MOTHER JONES, http://www.motherjones.com/politics/2000/11/growing-
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Antibiotic resistance in humans is a major health 
concern.11 Antibiotic resistant bacteria can pass from animals 
to humans.12 As humans become resistant to antibiotics, health 
care for treatable diseases becomes more costly.13 Antibiotic 
resistance can lead to hospitalization, longer-term care, and 
potentially even death.14 However, the cause of antibiotic 
resistance in humans is difficult to determine.15 Some studies 
have found a causal link between antibiotic use in animals and 
antibiotic resistance in humans.16 However, antibiotics are 
given to animals in such low doses that antibiotic resistance 
may be the consequence of over-use of antibiotics among 
humans.17 While there is some evidence of a linkage between 
                                                          
resistance (last visited Sept. 5, 2013) (estimating approximately forty percent 
of all antibiotics are used in animals). 
 11. See, e.g., Lessing, supra note 5, at 476; Briceño, supra note 4, at 521. 
 12. See Centner, supra note 7, at 26–27 (“Resistant bacteria in animals 
are passed to humans through the consumption of contaminated meat, [and] 
the handling of food products . . . .”); Lessing, supra note 5, at 474 (“There are 
three main ways in which antibiotic use—and therefore antibiotic resistance—
in animals is transferred to humans: via food, via human contact with 
livestock, and via the environment.”); O’Brien, supra note 1, at 426 
(“[C]onsumers pick . . . up [resistant strains of bacteria] by eating 
contaminated foods.”). 
 13. Centner, supra note 7, at 13; Richard S. Saver, In Tepid Defense of 
Population Health: Physicians and Antibiotic Resistance, 34 AM. J.L. & MED. 
431, 441 (2008); Antibiotic/Antimicrobial Resistance, CENTERS FOR DISEASE 
CONTROL & PREVENTION, http://www.cdc.gov/drugresistance/index.html (last 
updated Sept. 19, 2012); see Goforth & Goforth, supra note 6, at 67. 
 14. See Centner, supra note 7, at 13 (discussing how antibiotic resistance 
has led to more human suffering and death); Saver, supra note 13, at 441 
(discussing how antibiotic resistance has a mortality risk, along with longer 
hospital stays, more follow-up care, and a greater risk of complications); 
Briceño, supra note 4, at 521 (discussing how antibiotic resistance can lead to 
hospitalization and severe side effects). 
 15. See, e.g., Robert R. Nelson, Antibiotics in Animal Feeds: Short-Term 
Economics v. Long-Term Health, 31 S.D. L. REV. 416, 421 (1986) (discussing 
the difficulty in determining where someone’s antibiotic resistance came 
from); Goforth & Goforth, supra note 6, at 51 (questioning whether antibiotic 
use in farm animals has actually contributed to the growing amount of 
antibiotic resistant bacteria). 
 16. See Goforth & Goforth, supra note 6, at 48–49, 53; Briceño, supra note 
4, at 525. 
 17. See O’Brien, supra note 1, at 424 (discussing how human overuse of 
antibiotics likely contributes to antibiotic resistance). 
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antibiotic use in animals and antibiotic resistance in humans, 
no direct connection has been established.18 
Three governmental agencies, the U.S. Food and Drug 
Administration (FDA), the Centers for Disease Control and 
Prevention (CDC), and the U.S. Department of Agriculture 
(USDA), all play a role in the regulation of antibiotics—in both 
animals and people.19 Each of these agencies has an interest in 
regulations developed to control and slow the spread of 
antibiotic resistance.20 These agencies have formed the 
National Antimicrobial Resistance Monitoring System 
(NARMS), to monitor the spread of antibiotic resistance among 
people.21 The FDA is the agency with primary rulemaking 
authority for regulating antibiotic use in animals.22 So far, the 
FDA has not banned many classes of antibiotics from animal 
use.23 Because the FDA has taken little action, there is limited 
case law governing the use of antibiotics in animals.24 The FDA 
has issued a guidance document discussing the recommended 
proper use of antibiotics in animals.25 This guidance document 
provides a framework to eliminate the unnecessary and 
inappropriate use of antibiotics in food-producing animals.26 
                                                          
 18. See Lessing, supra note 4, at 474 (discussing how there is 
circumstantial evidence linking antibiotic use in animals to the increase in 
antibiotic resistance in people); see also Goforth & Goforth, supra note 6, at 64 
(discussing how there is an “ideal situation” created by the high amount of 
antibiotics used in animal feed for the growth of antibiotic-resistant bacteria). 
 19. See Nancy E. Halpern, Antibiotics in Food Animals: The Convergence 
of Animal and Public Health, Science, Policy, Politics and the Law, 14 DRAKE 
J. AGRIC. L. 401, 423 (2009) (discussing the roles of the FDA, CDC, and USDA 
in the regulation of antibiotic use). 
 20. See id. 
 21. See, e.g., FDA Announces Availability of the NARMS Strategic Plan 
2012–2016, FOOD & DRUG ADMIN. (May 25, 2012), http://www.fda.gov/
AnimalVeterinary/NewsEvents/CVMUpdates/ucm305710.htm. 
 22. See, e.g., Halpern, supra note 19, at 423; Briceño, supra note 4, at 530. 
 23. See Cephalosporin Order of Prohibition Questions and Answers, FDA, 
http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm054434.
htm (last updated July 22, 2013). 
 24. See infra Part I.A.2. 
 25. CTR. FOR VETERINARY MED., FDA, GUIDANCE FOR INDUSTRY #209: 
THE JUDICIOUS USE OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS IN 
FOOD-PRODUCING ANIMALS 4 (2012) [hereinafter GUIDANCE #209], 
available  at http://www.fda.gov/downloads/AnimalVeterinary/
GuidanceComplianceEnforcement/GuidanceforIndustry/UCM216216.pdf. 
 26. Id. (describing how the guidance document provides strategies 
promulgated by the FDA to limit the amount of use of antibiotics that are 
important to human health). 
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Conflicts could develop between the governmental 
agencies, since they all have an interest in how antibiotic use 
in animals is regulated.27 Once one main governmental 
authority is designated by Congress to have complete 
regulatory control, the question becomes: what actions should 
that agency take? There is pressure from some consumers to 
increase regulations,28 while the farming industry wants the 
current regulations to remain.29 
This Note makes recommendations for which government 
agency should be in complete control over the issue of antibiotic 
use in animals and what action that agency should take. Part I 
will describe the current regulation of antibiotic use in animals. 
Part II will analyze which government agency is best suited to 
have primary rulemaking authority and weigh the options for 
what steps should be taken next. Finally, this Note will 
conclude that the FDA is the agency that should be given 
primary regulatory control, and it should begin banning the use 
of antibiotics in animals. 
I. BACKGROUND: ANTIBIOTICS, ANTIBIOTIC 
RESISTANCE, CURRENT REGULATIONS, AND 
REGULATORY BODIES 
Antibiotics are a type of drug used to treat bacterial 
infections.30 Antibiotics are not effective against viral infections 
such as influenza, most ear infections, and the common cold.31 
Antibiotics operate by killing off the bacteria in the human 
                                                          
 27. See, e.g., Centner, supra note 7, at 17 (discussing how there are 
problems with coordination because there are three agencies involved in the 
regulation of antibiotic use in animals). 
 28. See id. at 23 (discussing how some consumers are willing to pay a 
higher price for “antibiotic-free meat products”). 
 29. See id. at 24 (discussing how the farming industry wants to maintain 
its current production and management practices based on “economic, 
business, and social interests,” which it would not be able to do if antibiotic 
use in animals was banned). 
 30. E.g., U.S. Nat’l Library of Med. & Nat’l Insts. of Health, Antibiotics, 
MEDLINE PLUS, http://www.nlm.nih.gov/medlineplus/antibiotics.html (last 
updated Aug. 16, 2013) [hereinafter Antibiotics]; Get Smart: Know When 
Antibiotics Work, Fast Facts, CENTERS FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/getsmart/antibiotic-use/fast-facts.html (last updated Jan. 
21, 2011) [hereinafter Fast Facts]. 
 31. E.g., Mayo Clinic Staff, Antibiotics: Misuse Puts You and Others at 
Risk, MAYO CLINIC (Feb. 4, 2012), http://www.mayoclinic.com/health/
antibiotics/FL00075. 
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body or by preventing the bacteria from multiplying.32 A 
problem arises when the bacteria within the body develop a 
mutation thereby making the antibiotic ineffective in killing off 
the bacteria.33 This mutation, commonly called antibiotic 
resistance, can develop from a variety of sources, such as 
overuse34 and inappropriate use.35 
Inappropriate use occurs when an antibiotic is used to 
treat a disease that it was not intended to treat.36 One study 
has shown that pediatricians are more likely to prescribe an 
antibiotic when they perceive that the parent wants them to 
prescribe it, even if the antibiotic will likely be ineffective in 
treating the disease.37 Inappropriate use can also occur when a 
patient does not follow the prescribed instructions, such as not 
taking the antibiotic for the entire length of prescribed time.38 
Overuse of antibiotics is also a leading cause of antibiotic 
                                                          
 32. See Antibiotics, supra note 30. 
 33. About Antimicrobial Resistance: A Brief Overview, CENTERS FOR 
DISEASE CONTROL & PREVENTION, http://www.cdc.gov/drugresistance/
about.html (last updated July 2, 2012) (“[T]he infectious organisms that 
antibiotics are designed to kill have adapted to them, making the drugs less 
effective.”). 
 34. See Mikaela Conley, Overuse of Antibiotics May Cause Long-Term 
Harm, ABC NEWS (Aug. 25, 2011), http://abcnews.go.com/Health/antibiotics-
bad-good-bacteria/story?id=14374547#.UKpD2YZtCSo (discussing how the 
overuse of antibiotics adds to the increase of human disease). 
 35. See Antimicrobial Resistance, WORLD HEALTH ORG. (2011), available 
at http://www.richmondinstitute.com/wp-content/uploads/2012/05/WHO-Fact-
Sheet-on-Antimicrobial-Resistance-2011.pdf (“Inappropriate and irrational 
use of antimicrobial medicines provides favourable [sic] conditions for 
resistant microorganisms to emerge, spread and persist.”); Fast Facts, supra 
note 30 (“Misuse of antibiotics jeopardizes the usefulness of essential drugs.”). 
 36. See Antimicrobial Resistance, supra note 35 (discussing some of the 
underlying factors that lead to antibiotic resistance, which include 
“inappropriate and irrational use of medicines”). 
 37. Fast Facts, supra note 30 (“For pediatric care, a study showed that 
doctors prescribe antibiotics 62% of the time if they perceive parents expect 
them and 7% of the time if they feel parents do not expect them.”). 
 38. Mayo Clinic Staff, supra note 31 (“Not taking antibiotics exactly as 
prescribed also leads to problems. For example, if you take an antibiotic for 
only a few days—instead of the full course—the antibiotic may wipe out some, 
but not all, of the bacteria.”). 
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resistance.39 Overuse of antibiotics can occur in animals, which 
can lead to antibiotic resistance in humans.40 
Antibiotic resistance is considered one of the world’s most 
concerning health issues.41 Some scientists argue that 
antibiotic resistance could put the world back to a pre-
antibiotic time.42 Bacterial infections that are now resistant to 
antibiotics are more difficult to treat.43 When bacteria are 
resistant to the antibiotic developed to treat a condition, a 
second- or even third-choice drug will be used.44 These second- 
or third-option drugs are usually not as effective at treating the 
infection.45 As a result, patients can be hospitalized and have to 
undergo prolonged treatment.46 In some cases, antibiotic 
resistance can lead to patient death.47 
A. CURRENT FDA REGULATIONS FOR ANTIBIOTIC USE IN 
ANIMALS 
Antibiotics used in animals are regulated when these 
drugs first come into the market under the rules regulating 
“new animal drugs.”48 Before a new animal drug can be used, a 
                                                          
 39. See Mission Critical: Preventing Antibiotic Resistance, CENTERS FOR 
DISEASE CONTROL & PREVENTION, http://www.cdc.gov/features/
antibioticresistance/ (last updated Nov. 7, 2012). 
 40. Cf. O’Brien, supra note 1, at 424 (“Human overuse [of antibiotics] 
certainly contributes to this problem, but the volume of antibiotics 
administered to animals vastly exceeds the amount taken by humans.”). 
 41. E.g., Fast Facts, supra note 30 (“Antibiotic resistance has been called 
one of the world’s most pressing public health problems.”). 
 42. Cf. Antimicrobial Resistance, supra note 35 (“The achievements of 
modern medicine are put at risk by [antibiotic resistance].”). 
 43. See About Antimicrobial Resistance: A Brief Overview, supra note 33 
(discussing how alternative treatments can be less effective). 
 44. See Antimicrobial Resistance, supra note 35 (“When infections become 
resistant to first-line medicines, more expensive therapies must be used.”). 
 45. E.g., About Antimicrobial Resistance: A Brief Overview, supra note 33 
(“When the drug of choice for treating [the patient’s] infection doesn’t work, 
they require treatment with second- or third-choice drugs that may be less 
effective, more toxic, and more expensive.”). 
 46. See Mayo Clinic Staff, supra note 31 (noting that antibiotic resistance 
can lead to “more doctor visits or extended hospital stays”). 
 47. E.g., Antimicrobial Resistance, supra note 35 (discussing how 
antibiotic resistance increases the risk of death); About Antimicrobial 
Resistance: A Brief Overview, supra note 33 (stating that a patient “may be 
more likely to die as a result of the infection”). 
 48. 21 U.S.C. § 321(v) (2012) (“The term ‘new animal drug’ means any 
drug intended for use for animals other than man, including any drug 
intended for use in animal feed . . . .”). 
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new drug application must be filed.49 The FDA is responsible 
for determining whether “the drug is safe and effective for its 
intended use and that any residue that may exist in animal-
based food is safe with regard to human health.”50 Unless and 
until a new animal drug application is approved, the drug is 
deemed unsafe for use.51 In order to be approved, the drug 
must be shown to be safe, effective, a quality manufactured 
product, and must be properly labeled.52 If the drug is intended 
to be used in food-producing animals, the FDA may require the 
development of a method to measure high drug residues in the 
food-product consumed by humans.53 If the drug is approved, 
an allowable level for use in animal feed is established.54 This 
maximum level is intended to prevent drug residues from 
ending up in the edible food product.55 However, the FDA can 
only require a method to measure high levels of residues and a 
maximum level of residue if “there is a reasonable probability 
that a use of an animal drug . . . may present a risk to the 
public health . . . .”56 
1.  Withdrawal Procedure 
Once a drug is approved for animal use, it can be difficult 
for approval to be withdrawn.57 There is a specific procedure 
                                                          
 49. 21 U.S.C. § 360b(a)(1) (2012). 
 50. Halpern, supra note 19, at 424. 
 51. 21 U.S.C. § 360b(a)(1) (“A new animal drug shall . . . be deemed 
unsafe for purposes . . . of this title . . . unless [approved] . . . .”); New Animal 
Drug Applications, FOOD & DRUG ADMIN., http://www.fda.gov/
AnimalVeterinary/DevelopmentApprovalProcess/NewAnimalDrugApplication
s/default.htm (last updated Nov. 13, 2012) (discussing how a new animal drug 
may not be sold until its new animal drug application has been approved). 
 52. Office of New Animal Drug Evaluation, FOOD & DRUG ADMIN., 
http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CVM/WhatWeDo/
ucm077923.htm (last updated Nov. 13, 2012) (listing and describing the four 
requirements a new animal drug must meet in order to be approved). 
 53. 21 U.S.C. § 360b(a)(4)(B)(ii). 
 54. Id. § 360b(a)(4)(B); Halpern, supra note 19, at 424; LaVerne C. 
Harold, What Level of Drugs Can Be Used in Feeds?, 16 FOOD DRUG COSM. 
L.J. 239, 242 (1961). 
 55. See, e.g., Halpern, supra note 19, at 424 (2009); LaVerne, supra note 
54, at 242 (“The quantity and combination of drugs as permitted by the 
different paragraphs . . . of the antibiotic feed regulations must be kept at a 
level in a feed which will prevent drug residues in edible products.”). 
 56. 21 U.S.C. § 360b(a)(4)(B). 
 57. See Briceño, supra note 4, at 530 (“Courts have interpreted 
[withdrawal procedure from the FDCA] to mean that the FDA has the initial 
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that the FDA must follow in order to withdraw an animal drug 
from the market, which includes producing adequate evidence 
to show the potential dangers of the drug.58 Once the FDA has 
obtained evidence that an animal drug is unsafe, they must 
provide notice to the drug’s sponsor and allow the sponsor the 
opportunity for a hearing.59 After the hearing the animal drug 
may be withdrawn, but only if the FDA finds one of the 
statutory scenarios to be true.60 Because of the strict 
withdrawal procedure, the FDA has not withdrawn many 
antibiotics from use in animals.61 However, on July 28, 2005 
the FDA withdrew its approval of Baytril® “because it was 
contributing to the increase of antibiotic-resistant bacterial 
infections in humans.”62 Baytril® was a drug that was being 
used in farm animals,63 and it had a similar chemical structure 
to a drug called Cipro.64 Cipro was used in humans to treat 
food-borne illnesses, including salmonella.65 The only other 
antibiotic to have its approval withdrawn is cephalosporin in 
early 2012.66 Cephalosporins are a class of antibiotics that are 
                                                          
burden, and must show that there are ‘serious questions’ as to a drug’s safety.” 
(footnotes omitted)); GUIDANCE #209, supra note 25, at 18 (“Under [the 
withdrawal] provision, if FDA initiates a withdrawal action, it must produce 
evidence to show that there is a reasonable basis from which serious questions 
may be inferred about the ultimate safety of the drug and any substance that 
may be formed in or on food as a result of use of such drug under approved 
conditions.”). 
 58. Briceño, supra note 4, at 530 (discussing the FDA’s procedure for 
having a drug’s approval withdrawn). 
 59. 21 U.S.C. § 360b(e)(1). 
 60. See id. The statute lists possible scenarios where a new animal drug’s 
approval may be withdrawn. Id. This list includes: experimental data showing 
the drug is unsafe for the use it was approved for, new evidence not available 
at the time the application was submitted—examined together with the 
evidence available at the time of the application showing the drug is unsafe, or 
the application contained a false statement. Id. 
 61. The FDA has withdrawn approval of Baytril® and cephalosporins. 
Infra notes 62–68 and accompanying text. 
 62. Lessing, supra note 5, at 477. 
 63. See Briceño, supra note 4, at 524–25 (“[E]nrofloxacin . . . is the key 
ingredient in Baytril® and an antibiotic that combats the presence of E. coli 
and other bacteria found in poultry.”); Lessing, supra note 5, at 477 
(discussing how Baytril® was being used in poultry). 
 64. Lessing, supra note 5, at 477. 
 65. Id. 
 66. See Cephalosporin Order, supra note 23. 
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used in humans.67 The ban on cephalosporins went into effect 
on April 6, 2012.68 
2.  Recent Case Law 
A recent case brought by Natural Resources Defense 
Council, Inc. against the FDA dealt with the lack of regulation 
on antibiotic use in animals.69 At issue was a 1977 FDA 
announcement declaring the Agency’s intention to withdraw 
approval for multiple antibiotics that were being used in 
animals;70 however, the FDA never took any action.71 The three 
antibiotics at issue in this case were penicillin and two forms of 
tetracyclines.72 In 1970, the FDA created a group of scientists 
to examine the risks of using these three antibiotics in animal 
feed.73 In 1972, the group determined that meat consumed by 
humans contained antibiotic resistant bacteria.74 The group 
also concluded that antibiotic resistance in humans was 
increasing.75 The scientists recommended that the FDA 
withdraw approval of nontherapeutic uses of penicillin and the 
                                                          
 67. Id. (“The cephalosporin class of drugs is important in treating human 
diseases, such as pneumonia, skin and tissue infections, pelvic inflammatory 
disease, and other conditions.”). 
 68. Cephalosporin Order of Prohibition Goes into Effect, FOOD & DRUG 
ADMIN. (Apr. 6, 2012), http://www.fda.gov/AnimalVeterinary/NewsEvents/
CVMUpdates/ucm299054.htm. 
 69. See Natural Res. Def. Council, Inc. v. FDA, 884 F. Supp. 2d 127, 130 
(S.D.N.Y. 2012). 
 70. See id. at 130. 
 71. Id. at 135 (“The Commissioner [of the FDA] never set a date for the 
hearings on the BVM’s [Bureau of Veterinary Medicine, a subdivision of the 
FDA] proposal to withdraw approval of the use of penicillin and tetracyclines 
in animal feed.”). 
 72. Id. at 132. 
 73. Id. (“[T]he agency convened a task force to study the risks associated 
with the use of antibiotics in animal feed. The task force was composed of 
scientists from the FDA, the National Institutes of Health, the U.S. 
Department of Agriculture, the Center for Disease Control, as well as 
representatives from universities and industry.”). 
 74. Id. (describing the findings of the task force, including that “the use of 
antibiotics in animal feed, especially at doses lower than those necessary to 
prevent or treat disease, favors the development of antibiotic-resistant 
bacteria,” that “animals receiving antibiotics in their feed may serve as a 
reservoir of antibiotic pathogens, which can produce human infections,” and 
that “antibiotic-resistant bacteria had been found on meat and meat 
products”). 
 75. Id. (describing the findings of the task force, including that “antibiotic 
resistant bacteria in humans had increased”). 
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two forms of tetracyclines for animals.76 Based on their 
recommendation, the FDA announced its intention to withdraw 
approval of all nontherapeutic uses of antibiotics in animals.77 
However, the FDA never scheduled the hearings required 
before withdrawal.78 In 2011, almost twenty-five years after the 
FDA announced its proposed withdrawal of approval, the FDA 
rescinded it.79 The Natural Resources Defense Council brought 
an action against the FDA alleging that the FDA violated 21 
U.S.C. § 360b(e)(1) by not scheduling the hearings in the 
process of withdrawing approval.80 The District Court 
concluded that the FDA was required to move forward with the 
steps to withdraw approval once the finding had been made 
that the drugs’ use in animals presented a potential health risk 
for humans.81 
In another case, Animal Legal Defense Fund Boston, Inc. v. 
Provimi Veal Corp., the Animal Legal Defense Fund Boston 
(ALDF) argued that Provimi, a producer of veal, should be 
required “to tell consumers that its veal . . . comes from calves 
that are fed antibiotics subtherapeutically.”82 The ALDF 
believed that the antibiotics placed in the calves’ feed was a 
danger to human health83 and that without providing this 
information to consumers, people were unknowingly putting 
themselves at risk.84 The ALDF brought the claim against 
                                                          
 76. Id. at 132–33 (“The task force made several recommendations, 
including that (1) antibiotics used in human medicine be prohibited from use 
in animal feed unless they met safety criteria established by the FDA, and (2) 
several specific drugs, including penicillin and tetracyclines, be reserved for 
therapeutic use unless they met safety criteria for non-therapeutic use.”). 
 77. Id. at 133 (stating that the FDA “propose[d] to withdraw approval of 
all subtherapeutic uses of antibiotics in animal feed unless drug sponsors and 
other interested parties submitted data within the next two years” that 
demonstrated that these drugs did not have negative side effects for humans). 
 78. Id. at 135. 
 79. Id. at 136 (“On December 16, 2011, nearly twenty-five years after 
their initial publication and during the pendency of this [court] action, the 
FDA rescinded the 1977 NOOHs [notices of an opportunity for hearing].”). 
 80. Id. at 137. 
 81. See id. at 148 (discussing the actions of the Commissioner of the FDA 
after the findings by the task force had been made, including agreeing that the 
drugs in question “had not been shown to be safe”). 
 82. 626 F. Supp. 278, 279 (D. Mass. 1986). 
 83. Id. at 278. 
 84. Id. at 279 (“[T]he ALDF claim[s] that Provimi ought to tell consumers 
that its veal might be unhealthful because it comes from calves that are fed 
antibiotics subtherapeutically.”). 
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Provimi under a Massachusetts consumer protection statute85 
and argued that not providing that information was a deceptive 
trade practice.86 The District Court concluded that the claim 
brought by the ALDF was preempted under the Federal Food, 
Drug, and Cosmetic Act (FDCA).87 The court stated that the 
FDCA regulates the amount of antibiotics placed in animal 
feed, and therefore, the ALDF could not sue under state law.88 
Without state law, the ALDF had no cause of action because it 
could not bring a claim under the FDCA.89 Ultimately, this case 
demonstrates that the solution to control antibiotic use in 
animals resides with regulatory agencies and not with the 
courts.90 
B. ISSUE WITH MULTIPLE GOVERNMENTAL AGENCIES 
COMPETING FOR CONTROL 
Within the United States government, there are three 
agencies and one group that all have a role in regulating 
antibiotic use in animals.91 These different agencies must work 
together to slow the spread of antibiotic resistance stemming 
from meat and poultry consumption.92 The United States is not 
the only country concerned with the spreading of antibiotic 
resistance. International organizations are also stepping 
forward to help reduce antimicrobial resistance.93 In Europe, 
                                                          
 85. Id. at 278. 
 86. See id. at 281 (describing the ALDF’s argument that by not telling 
Provimi’s consumers, Provimi was engaging in a deceptive trade practice 
because Provimi was not complying with a Massachusetts public health 
statute or regulation). 
 87. Id. at 282. 
 88. Id. (discussing how the FDA has authority to determine whether a 
new animal drug is safe for humans). 
 89. Id. at 283. 
 90. See, e.g., O’Brien, supra note 1, at 437 (“Provimi demonstrates that 
the battle to restrict or abolish the use of subtherapeutic doses of antibiotics in 
animals might not be fought and won in the courtroom . . . . [The court in the 
Provimi case] did state, however, that the decision to allow the subtherapeutic 
use of antibiotics is in the hands of . . . governmental regulatory agencies.”). 
 91. The three agencies are the FDA, the CDC, and the USDA. See 
Halpern, supra note 19, at 423. The group is NARMS, which is a collaboration 
of the three agencies. See FDA Announces Availability of the NARMS Strategic 
Plan 2012–2016, supra note 21. 
 92. See Halpern, supra note 19, at 423 (discussing how the three agencies 
collect data on antibiotic resistance in both humans and animals). 
 93. See Briceño, supra note 4, at 523 (discussing the World Health 
Organization); id. at 527 (discussing the European Union). 
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some countries have complete bans on non-therapeutic 
antibiotic use in animals.94 But because there is no direct link 
between antibiotic use in animals and antibiotic resistance in 
humans, countries have taken different approaches.95 When it 
comes to reducing the spread of antibiotic resistance, 
Europeans have generally acted more cautiously than the 
United States.96 
1.  FDA, CDC, USDA, and Collectively, NARMS 
The FDA has the statutory authority to approve new 
animal drugs.97 For drugs used in animals, the FDCA lists 
human health as a primary factor the FDA must consider when 
approving a new drug, “regardless of whether the drug is 
intended for human or animal[ ]” consumption.98 
The federal authority governing antibiotic use in food animals falls 
largely upon the FDA which approves applications of new animal 
drugs for sale. The FDA also regulates the manufacture and 
distribution of antibiotics used in animals, as prescribed by 
veterinarians or through access to licensed feed mills that add 
specific antibiotics to animal feed in subtherapeutic dosages for 
growth promotion.99 
If the FDA determines that a new animal drug may pose a 
threat to human health, the FDA can limit how much residue 
is allowed to be in meat products.100 Little guidance is provided 
in the FDCA as to how the limit is to be determined.101 The 
FDCA also contains permissive language, such as “may” 
instead of “must,” leaving the FDA discretion to make the final 
                                                          
 94. See Centner, supra note 7, at 15 (discussing how Sweden, Norway, 
Denmark, and Finland have all taken action to eliminate the use of antibiotics 
in animals). 
 95. Id. at 15 (“Given uncertainties accompanying purported risks, 
governments come to different conclusions when they make difficult rational 
decisions. The European Union and the United States have analyzed and 
evaluated uncertainties differently.” (footnote omitted)). 
 96. See id. at 15 (explaining that “Europeans have decided that the 
widespread uses of unnecessary feed additives . . . and antibiotics in animal 
production are not necessary and are exacerbating health problems,” and 
therefore, have enacted bans on these unnecessary uses of antibiotics). 
 97. Briceño, supra note 4, at 530 (discussing how FDA’s authority to 
regulate the use of antibiotics is based in the FDCA). 
 98. Id. at 530. 
 99. Halpern, supra note 19, at 423. 
 100. 21 U.S.C. § 360b(a)(4)(B) (2012). 
 101. See id. 
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decisions.102 The FDA’s decisions regarding new animal drugs 
can be influenced by a variety of other groups, including other 
agencies.103 
Even though the FDA has statutory rulemaking authority 
when it comes to animal drugs, the CDC and the USDA also 
have an interest in regulating antibiotic use in animals.104 The 
CDC approaches the issue from the perspective of human 
antibiotic resistance.105 The USDA, on the other hand, is 
primarily concerned with the amount of drug residue that is 
present in meat eaten by consumers.106 The FDA is working 
with the CDC and the USDA separately, but there is also a 
collective group formed by all three—the National 
Antimicrobial Resistance Monitoring System (NARMS).107 
NARMS was formed in 1996 to begin monitoring changes 
in the reaction of salmonella to antibiotics in both humans and 
animals.108 NARMS currently monitors the spread of antibiotic 
resistance in humans and then “provides [this] information to 
veterinarians and physicians . . . [and] aids in antimicrobial 
resistance research . . . .”109 NARMS is designed to focus on 
                                                          
 102. See id. 
 103. See infra Part II.B–C for a discussion about the USDA and the CDC. 
 104. See Halpern, supra note 19, at 423 (discussing how the CDC and 
USDA work with the FDA to collect data on antibiotic resistance occurring in 
both humans and animals). 
 105. See William M. Sage & David A. Hyman, Combating Antimicrobial 
Resistance: Regulatory Strategies and Institutional Capacity, 84 TUL. L. REV. 
781, 828 (2010) (“The CDC is generally the lead agency on federal drug-
resistance initiatives, including the interagency task force on the problem.”). 
The CDC has also recently “confirmed a link between routine use of antibiotics 
in livestock and growing bacterial resistance.” Carolyn Lockhead, CDC Warns 
Against Overuse of Antibiotics, NEWS TIMES (Sept. 16, 2013, 8:21 AM), 
http://www.newstimes.com/local/article/CDC-warns-against-overuse-of-
antibiotics-4819478.php. The CDC believes there is enough evidence to show 
that antibiotic use in animals is leading to antibiotic resistance in humans. 
See id. 
 106. See Nelson, supra note 15, at 420–21 (discussing the USDA program 
that tests for drug residues in animal food products). 
 107. See supra note 91 and accompanying text. 
 108. See, e.g., Marcia L. Headrick, CVM Conducts Retail Meat Pilot Study, 
FOOD & DRUG ADMIN., http://www.fda.gov/AnimalVeterinary/NewsEvents/
FDAVeterinarianNewsletter/ucm106078.htm (last updated Apr. 16, 2013) 
(“NARMS was initiated in 1996 and initially monitored changes in 
antimicrobial susceptibilities of . . . Salmonella, isolated from human and 
animal clinical specimens, from carcasses of food-producing animals and 
animal products at processing, and from on-farm samples.”). 
 109. Id. 
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antibiotic resistance that originates in foodborne resistant 
bacteria.110 NARMS has no rulemaking authority; it only 
monitors and collects data on the spread of antibiotic 
resistance.111 Each year NARMS issues a report on all of its 
findings,112 and the data collected is intended to help the FDA 
in issuing new regulations.113 
However, it appears that the research done by NARMS has 
not been used to work towards any new regulations.114 
NARMS’s most recent report showed patterns of increasing 
antibiotic resistance for some strains of salmonella and 
                                                          
 110. See National Antimicrobial Resistance Monitoring System, FOOD & 
DRUG ADMIN., http://www.fda.gov/AnimalVeterinary/SafetyHealth/
AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/
default.htm (last updated Apr. 22, 2013) (“NARMS monitors antimicrobial 
susceptibility among . . . bacteria from humans, retail meats, and food 
animals.”); National Antimicrobial Resistance Monitoring System for Enteric 
Bacteria (NARMS), CENTERS FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/narms (last updated Sept. 30, 2013); NARMS—National 
Antimicrobial Resistance Monitoring System Animal Isolates, U.S. DEP’T 
AGRIC., http://www.ars.usda.gov/Main/docs.htm?docid=6750 (last updated 
May 1, 2012). 
 111. See National Antimicrobial Resistance Monitoring System, supra note 
110 (listing NARMS’s objectives, which include monitoring resistance, 
conducting research on the spread of antibiotic resistant bacteria, and helping 
the FDA in making regulatory decisions); National Antimicrobial Resistance 
Monitoring System (NARMS): Enteric Bacteria, supra note 110; NARMS—
National Antimicrobial Resistance Monitoring System Animal Isolates, supra 
note 110. 
 112. See, e.g., National Antimicrobial Resistance Monitoring System: 
NARMS Annual Reports, CENTERS FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/narms/reports.html (last updated Sept. 16, 2013) (listing 
all the past NARMS Annual Reports summarizing surveillance information on 
antimicrobial resistance). 
 113. See FDA Announces Availability of the NARMS Strategic Plan 2012–
2016, supra note 21; NARMS—National Antimicrobial Resistance Monitoring 
System Animal Isolates, supra note 110; National Antimicrobial Resistance 
Monitoring System, supra note 110; National Antimicrobial Resistance 
Monitoring System (NARMS): Enteric Bacteria, supra note 110. 
 114. See Gretchen Goetz, New Data on Antimicrobial Resistance a Mixed 
Bag: While Some Salmonella and Campylobacter Stains Grew in Resistance, 
Others Fell, Finds NARMS, FOOD SAFETY NEWS (Aug. 1, 2012), 
http://www.foodsafetynews.com/2012/08/new-data-on-antimicrobial-resistance-
a-mixed-bag (discussing how the FDA is requiring more information to 
determine which antibiotics are contributing to the resistance). While the 
NARMS data has not been used to form new regulations, it has been used in 
the past to withdraw approval for a poultry antibiotic. See, e.g., id.; see also 
supra Part I.A (discussing the withdrawal of approval of Baytril®). 
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campylobacter.115 The FDA has stated that while the data may 
show a trend, it does not provide definitive evidence of 
antibiotic use in animals leading to antibiotic resistance in 
humans.116 Without a more definite link between the two, the 
FDA has decided to wait to act.117 In contrast, other countries 
have adopted a more cautious approach even without a direct 
link and have enacted bans or severely limited the use of 
antibiotics in animals.118 
2.  The World Health Organization and the European Union 
Antibiotic use in animals is not just a concern within the 
United States, but worldwide.119 The World Health 
Organization (WHO) has declared that “a main source of 
resistant bacteria is the overuse of antibiotics in animals.”120 
The WHO has published guidelines on the best ways to stop the 
spread of antibiotic resistance within food-producing 
animals.121 The WHO has pushed for a ban of antibiotics that 
are used as growth promoters in animals, especially when 
those antibiotics are also used in human healthcare.122 The 
                                                          
 115. NARMS, NATIONAL ANTIMICROBIAL RESISTANCE MONITORING 
SYSTEM: ENTERIC BACTERIA 2011, HUMAN ISOLATES FINAL REPORT, CENTERS 
FOR DISEASE CONTROL & PREVENTION 12–13 (2011), available at 
http://www.cdc.gov/narms/pdf/2011-annual-report-narms-508c.pdf; Goetz, 
supra note 114. 
 116. See, e.g., Goetz, supra note 114 (“[W]hile this data reflects some trends 
in resistance among strains, it does not provide definitive evidence of which 
drugs lead to resistance in human strains when used in animals.”). 
 117. See id. (discussing how without a direct link it is difficult for the FDA 
to decide what actions to take next and how the FDA is working to obtain a 
more direct correlation). 
 118. See Centner, supra note 7, at 15 (discussing how Sweden, Norway, 
Denmark, and Finland have all taken action to eliminate the use of antibiotics 
in animals). 
 119. See Briceño, supra note 4, at 523 (discussing the World Health 
Organization’s involvement and concern); id. at 527 (discussing the European 
Union’s involvement and concern). 
 120. Id. at 523. 
 121. See, e.g., id. (“[T]he WHO has issued global guidelines on how to 
contain antimicrobial resistance developing in animals raised for food.”). 
 122. See WHO GLOBAL STRATEGY FOR CONTAINMENT OF ANTIMICROBIAL 
RESISTANCE, WORLD HEALTH ORG. 5 (2001), available at 
http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf 
(recommending termination “or rapidly phase[ing] out the use of 
antimicrobials for growth promotion if they are also used for treatment of 
humans”). 
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WHO also has been an international leader in pushing for a 
complete ban on antibiotic use in animals.123 
The European Union (EU) is also a proponent of 
eliminating the use of antibiotics in farm animals.124 Within 
the EU, the European Commission (EC) proposes new 
legislation to the other branches of the EU and works with the 
member nations in implementing the EU laws.125 In 2011, the 
EC developed an action plan to slow the spread of antibiotic 
resistance.126 Part of the action plan includes strengthening the 
laws on medicated animal feed.127 This action plan is a 
continuation of previous EU regulations banning certain drugs 
used in animal feed.128 Some European nations’ policies 
preceded the EU regulations by significantly cutting down on 
the use of antibiotics in animals.129 Before these bans were 
implemented, European studies demonstrated how antibiotic 
use in animals could lead to antibiotic resistance in humans.130 
One study demonstrated that over time, pigs fed with 
medicated feed carried antibiotic-resistant bacteria, as did the 
farmers and other local community members.131 Such studies 
                                                          
 123. See Centner, supra note 7, at 16 (“For ten years, the World Health 
Organization has recommended the elimination of growth promoters in 
animal production for antimicrobial agents that are used in human 
therapeutics or are known to select for cross-resistance to antimicrobials used 
in human medicine.”). 
 124. See, e.g., Briceño, supra note 4, at 527 (“The European Union has 
passed legislation banning all non-therapeutic antibiotics in livestock.”). 
 125. See European Commission at Work, EUR. COMM’N, 
http://ec.europa.eu/atwork/index_en.htm (last updated June 28, 2013). 
 126. See Action Plan Against Antimicrobial Resistance: Commission 
Unveils 12 Concrete Actions for the Next 5 Years, EUR. COMM’N (Nov. 17, 
2011), http://europa.eu/rapid/press-release_IP-11-1359_en.htm?locale=en 
(setting out twelve concrete actions that the EC will work towards over the 
next few years). 
 127. Id. 
 128. See Lessing, supra note 5, at 477 (“Legislation regulating antibiotic 
use in animals has been enacted since 1986 . . . . In 1998, the European 
Union . . . withdrew approval for four animal feed additives.” (footnote 
omitted)). 
 129. See Centner, supra note 7, at 15–16 (discussing the actions different 
European countries have taken to prevent the spread of antibiotic resistance). 
 130. See Goforth & Goforth, supra note 6, at 53 (discussing a study 
performed in the former East Germany); id. at 53–54 (discussing some 
bacterial infection outbreaks and how some cases were traced back to infected 
animal products). 
 131. Id. at 53 (discussing a study from the former East Germany where a 
farmer fed his swine antibiotics, which caused the pigs, the farmer, and the 
602 MINN. J. L. SCI. & TECH. [Vol. 15:1 
 
have led the EU to err on the side of caution and implement 
bans on unnecessary uses of antibiotics in animals.132 
II. POSSIBLE RESOLUTIONS TO THE LACK OF 
REGULATION 
In order to reduce the spread of antibiotic resistance, the 
use of antibiotics has to be controlled.133 There are conflicting 
ideas as to how the use of antibiotics in animals should be 
regulated.134 Currently, the FDA is taking a wait-and-see 
approach—that is, waiting until it has hard evidence before 
taking any action.135 But there are groups, such as the 
American Medical Association, the American Public Health 
Association, and the Humane Society of the United States, that 
are pushing for a complete ban on unnecessary use of 
antibiotics given to animals, even without conclusive evidence 
linking it to antibiotic resistance in humans.136 
                                                          
locals to all develop antibiotic-resistant bacteria seven years later; even 
though only the pigs were given the antibiotic, humans still had the antibiotic-
resistant bacteria in their bodies). 
 132. See Centner, supra note 7, at 14 (discussing the precautionary 
principle and how the EU has “decided to take precautionary action[s] by 
banning the use of antibiotics as animal growth promoters”). 
 133. See, e.g., id. at 29 (“Most scientists recognize that more prudent use of 
antibiotics in all areas is needed. While this may include banning some uses of 
non-therapeutic antibiotics, it also includes controlling the dissemination of 
antibiotics for therapy.” (footnotes omitted)); Jessica P. Schulman, Note, 
Patent and Public Health: The Problems With Using Patent Law Proposals to 
Combat Antibiotic Resistance, 59 DEPAUL L. REV. 221, 252 (2009) (“The best 
way to both slow the spread of antibiotic resistance and effectively use existing 
antibiotics involves . . . closely regulating antibiotic use . . . .”). 
 134. E.g., Centner, supra note 7, at 15 (discussing how countries can 
disagree on the best way to handle the issue of antibiotic resistance); Halpern, 
supra note 19, at 422 (“The FDA’s failure to prohibit subtherapeutic antibiotic 
use has been criticized by some public health advocates, while the decision to 
withdraw approval of one poultry antibiotic has been denounced by animal 
health advocates joined by the pharmaceutical and animal agricultural 
industries.”). 
 135. See Halpern, supra note 19, at 426 (“The FDA required enhanced 
testing and reporting of antibiotic use, but declined to ban the use of 
sulfonamides in all animal feed without sufficient evidence of harm to humans 
to counterbalance the benefits.”). 
 136. See Centner, supra note 7, at 16; Briceño, supra note 4, at 527–28 
(discussing how corporations such as McDonald’s and Bon Appétit are also 
putting pressure on the FDA to issue bans on nontherapeutic antibiotics). 
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A. TWO POSSIBLE SOLUTIONS: WAIT-AND-SEE OR IMMEDIATE 
ACTION 
Agencies and scientists agree that more evidence is needed 
in order to draw the conclusion that increases in antibiotic use 
in animals lead to the increase in antibiotic resistance among 
humans.137 The FDA has begun requiring more testing and 
reporting of the use of antibiotics in animals in order to assist 
in deciding what, if any, action should be taken next.138 Despite 
the push from some for the FDA to ban antibiotic use in 
animals,139 the lack of any hard evidence linking it to 
antimicrobial resistance makes it a difficult decision for the 
FDA.140 Industry groups are also weighing in, hoping to be able 
to continue using antibiotics in their animal feed.141 Overall, 
the benefits of a complete ban are uncertain.142 
The immediate action solution would qualify as the 
“precautionary principle.”143 Instead of waiting until antibiotic 
resistance has spread to withdraw approval, this solution 
would prevent it from happening144 (assuming there is a link 
between antibiotic use in animals and antibiotic resistance in 
                                                          
 137. See Halpern, supra note 19, at 422–23 (discussing how despite the 
disagreement over the strength of the current research data, all can agree that 
more data is needed). 
 138. See id. at 426; 21 C.F.R. § 558.15(b)–(c) (2013) (discussing how reports 
and updates must be submitted by “[a]ny person interested in developing data 
which will support retaining approval for such uses of . . . antibiotic[s]”). 
 139. See Briceño, supra note 4, at 527 (discussing how the EU and certain 
large-scale meat purchasers are pushing the FDA towards taking action). 
 140. See Centner, supra note 7, at 16–17 (“However, the absence of 
meaningful data on the amounts and use of non-therapeutic antibiotics in 
animal production in the United States makes it difficult to evaluate risks and 
justify a regulatory action that would withdraw their use.”); id. at 33 (“In the 
absence of sufficient data on antibiotic usage, it is impossible to accurately 
relate the use of non-therapeutic antibiotics to antibiotic-resistant human 
bacterial infections. This situation makes it difficult to alter the status quo 
whereby American law facilitates the widespread use of non-therapeutic 
antibiotics.” (footnote omitted)). 
 141. See id. at 32 (discussing how industry groups do not want antibiotics 
to be banned because if they were the industry groups would be required to 
adjust their production and management practices). 
 142. See id. at 15; Goforth & Goforth, supra note 6, at 66 (discussing the 
difficulty of quantifying the economic impact of regulating antibiotic usage). 
 143. Centner, supra note 7, at 13. 
 144. See id. at 14 (“Rather than adopting a reactive position whereby 
damages are awarded to injured persons, the precautionary principle seeks to 
prevent harm before it occurs.”). 
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humans). Animal activists are pushing for complete bans not 
just because of the possible benefits for human health, but also 
because of the likelihood of improvements in animal living 
situations.145 Because of the crowded conditions that animals 
are kept in, disease spreads easily.146 A ban of antibiotics would 
therefore likely lead to farmers changing the living conditions 
of the animals.147 There are a variety of possible drawbacks 
from a complete ban of antibiotics, including food costs 
rising,148 an increase in the risk of sick animals,149 and the 
potential for drug companies to stop developing new 
antibiotics.150 
B. TOO MANY AGENCIES CREATES CONTROL ISSUES 
These potential solutions add to the conflict between the 
governmental agencies. Because the agencies approach the 
issue of antibiotic resistance from different perspectives, they 
could easily disagree on what the best solution is. Too many 
agencies with an interest in the regulation of antibiotic use in 
animals can create problems.151 While the FDA has primary 
rulemaking authority, the CDC and the USDA have an interest 
                                                          
 145. See O’Brien, supra note 1, at 426 (discussing the dual benefit of 
improving conditions for animals and protecting human health). 
 146. MATHEWS, supra note 4, at 7 (“In situations where livestock are 
concentrated, especially in hog and poultry feeding operations, diseases can 
spread rapidly, and disease outbreaks can take a far heavier toll if low levels 
of antimicrobial drugs are not fed.”); O’Brien, supra note 1, at 426 
(“Overcrowded conditions on the farm contribute to the need for . . . antibiotic 
use. The closer the confinement, the greater the chance that an infectious 
disease will afflict the herd.”). 
 147. O’Brien, supra note 1, at 426 (“[A ban] would ameliorate some of the 
overcrowded conditions in which farm animals live . . . .”). 
 148. Centner, supra note 7, at 17–18 (describing the concern that if 
antibiotics were banned feed costs would increase); Goforth & Goforth, supra 
note 6, at 64 (“[F]armers have attributed lower costs of meat, eggs, and milk to 
subtherapeutic doses of antimicrobials in animal feed.”); O’Brien, supra note 
1, at 438. 
 149. MATHEWS, supra note 4, at 7 (“Death losses and reduced production 
from diseases that had been prevented by feeding low levels of antimicrobial 
drugs could be costly.”). 
 150. Briceño, supra note 4, at 526 (“[P]harmaceutical companies are 
unlikely to pursue the development of new antibiotics designed to respond to 
these ‘superbugs’ because economic factors, as well as scientific limitations, 
make their development of limited value.”); Schulman, supra note 133, at 252 
(“[C]losely regulating antibiotic use or cycling the use of antibiotics would 
decrease the financial incentive for pharmaceuticals to develop antibiotics.”). 
 151. See supra Part I.B.1. 
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in how the issue is regulated, and they could influence the 
FDA’s decision-making.152 Each agency is approaching the 
issue from a different perspective and could disagree on the 
best way to regulate antibiotic use in animals.153 
Another concern with multiple agencies interested in how 
antibiotics are regulated is the uncertainty regarding which 
agency will work with the international agencies to develop a 
solution to slow the global spread of antibiotic resistance.154 
The WHO and EU have pushed their member nations to adopt 
the cautious approach and enact bans on antibiotics.155 The 
WHO and EU could begin putting pressure on the United 
States to follow their lead.156 With all of these agencies and 
international organizations putting pressure on the United 
States, one agency should be selected to have primary 
regulatory control. 
C. THE FDA NEEDS COMPLETE RULE-MAKING CONTROL OVER 
ANTIBIOTIC USE IN ANIMALS 
Because the CDC and the USDA approach the issue of 
antibiotic use in animals differently than the FDA,157 it is 
likely that the agencies will disagree on what action to take. 
The FDA is best suited to take complete regulatory control 
because it has statutory rulemaking authority over antibiotic 
use in animals.158 The FDA regulates animal drug use159 and is 
                                                          
 152. See Halpern, supra note 19, at 423 (discussing the CDC’s and the 
USDA’s roles in assisting the FDA). 
 153. See Nelson, supra note 15, at 421 (discussing how the USDA tests for 
drug residues in animal food products); Sage & Hyman, supra note 105, at 828 
(discussing how the CDC is the lead agency on “drug-resistance initiatives”). 
 154. See WHO GLOBAL STRATEGY FOR CONTAINMENT OF ANTIMICROBIAL 
RESISTANCE, supra note 122, at 11 (discussing how combating the spread of 
antibiotic resistance needs global action). 
 155. See supra Part I.B.2. 
 156. See Antimicrobial Resistance, WORLD HEALTH ORG., 
http://www.who.int/mediacentre/factsheets/fs194/en/ (last updated May 2013); 
Combat Antimicrobial Resistance, WORLD HEALTH ORG. (2011), 
http://www.who.int/world-health-day/2011/WHD201_FS_EN.pdf (“WHO will 
issue an international call for concerted action to halt the spread of 
antimicrobial resistance and recommends a six-point policy package for 
governments.”). 
 157. Supra note 153 and accompanying text. 
 158. See Briceño, supra note 4, at 530 (describing how the FDA’s authority 
to regulate antibiotic use in animals comes from the FDCA). 
 159. See id. 
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able to make animal antibiotic regulations without having to 
work with the CDC and the USDA. An easy way to ensure that 
the FDA has sole control of the issue is to have the agencies 
sign a Memorandum of Understanding (MOU).160 Multiple 
agencies commonly sign an MOU when they all have an 
interest in regulating an issue.161 An MOU can specify what 
each agency will be responsible for concerning the issue.162 The 
FDA, CDC, and USDA can sign an MOU specifying that the 
FDA has primary rulemaking authority to decide how 
antibiotic use in animals is regulated, while NARMS remains 
in place for the CDC and the USDA to monitor the spread of 
antibiotic resistance. NARMS can continue to function as a way 
for all three agencies to work together to conduct research on 
how much antibiotics is used in animals and how rapidly 
antibiotic resistance is spreading among humans.163 
The FDA is also best suited to work with international 
groups. The FDA has hosted discussions with the international 
community about other health concerns in the past, which 
shows the Agency’s willingness to work across borders to 
develop solutions to pressing issues.164 The WHO has 
emphasized that antibiotic resistance is a global issue and 
wants to work with rulemaking bodies worldwide in order to 
develop an international solution.165 The WHO would likely 
want to work with the FDA, since the FDA is the agency with 
the rulemaking authority for antibiotic use in animals.166 The 
FDA could form an international MOU with the EU and the 
                                                          
 160. See FDA Memoranda of Understanding, FOOD & DRUG ADMIN., 
http://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnde
rstandingMOUs/default.htm (last updated June 26, 2012). 
 161. See id. (describing the MOU as an agreement between the FDA and 
another governmental agency and constitutes an understanding between the 
parties). 
 162. See MOU 225-78-1002, FOOD & DRUG ADMIN., http://www.fda.gov/
AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/Do
mesticMOUs/ucm116214.htm (last visited Mar. 10, 2009). 
 163. See supra Part I.B.1. 
 164. International Activities—FDA Hosts International BSE Discussions, 
FOOD & DRUG ADMIN., http://www.fda.gov/AnimalVeterinary/NewsEvents/
FDAVeterinarianNewsletter/ucm093920.htm (last updated Apr. 18, 2013). 
 165. See Antibiotic Resistance, supra note 35 (“WHO calls on all key 
stakeholders, including policy-makers and planners . . . to act and take 
responsibility for combating antimicrobial resistance.”). 
 166. See supra Part I.B.1 (discussing the FDA’s statutory rulemaking 
authority on this issue). 
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WHO in order to clarify how these different organizations will 
work together to combat antibiotic resistance.167 
D. PROBLEMS WITH POSSIBLE REGULATION SOLUTIONS 
The United States lags behind Europe when it comes to 
regulating antibiotic use in animals.168 European countries 
have adopted a more cautious approach by implementing bans 
on antibiotic use in animals.169 Instead of following the lead of 
the WHO or the EU, the FDA has adopted a wait-and-see 
approach.170 The FDA is currently performing research to see if 
there is a link between antibiotic use in animals and antibiotic 
resistance in humans,171 while allowing all approved antibiotics 
to remain in use.172 A direct link between antibiotic use in 
animals and antibiotic resistance in humans might never be 
found.173 But there is circumstantial evidence linking the 
two,174 and that should be enough for the FDA to take action, 
                                                          
 167. See Memoranda of Understanding and Other Cooperative 
Arrangements, FOOD & DRUG ADMIN., http://www.fda.gov/
InternationalPrograms/Agreements/MemorandaofUnderstanding/default.htm 
(last updated Dec. 13, 2012) (listing all of the FDA’s international MOUs, one 
of which is between the FDA and the EU). 
 168. See Centner, supra note 7, at 14 (discussing the EU’s precautionary 
ban on antibiotics as compared to the United States’ approach); supra Part 
I.B.2. 
 169. Centner, supra note 7, at 15 (discussing how Sweden, Norway, 
Denmark, and Finland have all implemented bans). 
 170. See supra Part I.C.1. 
 171. NARMS is in place to monitor the spread of antibiotic resistance. See 
Headrick, supra note 108 (“NARMS also facilitates the identification of 
[antibiotic] resistance in humans and animals as it arises . . . .”); see also 
supra Part I.B.1. (discussing the role of NARMS). 
 172. Halpern, supra note 19, at 426 (discussing how the FDA has 
reexamined antibiotic use in animals, but has continued to let antibiotics be 
used in animals); supra Part I.B.1. 
 173. See Nelson, supra note 15, at 421 (“[I]t is often difficult if not 
impossible to find the exact source of the residue contamination as well as the 
concrete link from antibiotics in animal feed directly to the injured human 
consumer of the food product.”). 
 174. See supra Part I.B.2. (discussing the study performed in the former 
East Germany which showed that there was likely a link between antibiotic 
use in swine and humans); see also Lessing, supra note 4, at 473–74 
(discussing how antibiotic use in animals may be linked to antibiotic 
resistance in humans). An example of circumstantial evidence is when 
chickens in the Netherlands became increasingly resistant to fluoroquinolone, 
human resistance to fluoroquinolone also increased. Id. 
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especially because antibiotic resistance poses a threat to 
human health.175 
While the wait-and-see approach is not a good solution, 
neither is a complete ban of all antibiotic use in animals. An 
across-the-board ban on antibiotic use in animals would likely 
lead to high costs for both farmers and consumers.176 Farmers 
would have to change the living conditions of their animals.177 
Currently, animals are kept in crowded conditions, which can 
lead to the spread of disease among the animals.178 If all 
antibiotics were banned, farmers would have to implement 
major changes to their farms to decrease the spread of 
disease.179 Even with different living conditions, there still is 
the possibility of animals contracting diseases.180 A complete 
ban on antibiotics might lead to more animals getting sick 
because farmers would have nothing to use to treat their 
                                                          
 175. Centner, supra note 7, at 14 (“Due to evidence suggesting that 
antibiotics used in animal production contribute to antibiotic resistance, the 
response can be justified under the precautionary principle.”); Nelson, supra 
note 15, at 421 (“[T]he possibility that potential health hazards exist is alone 
sufficient for the FDA to propose and Congress to pass a ban.”). 
 176. Farmers would have to pay to change the living conditions of animals. 
See Centner, supra note 7, at 17–18 (discussing how a ban on antibiotics 
might lead to increased animal feed costs and change the animal production 
practices). Consumers would have to pay more for animal food products. Id. at 
19 (discussing how pork prices would likely rise after an antibiotic ban). 
 177. See Centner, supra note 7, at 17–18 (discussing how farmers oppose 
antibiotic bans because of the possible costs and changes); O’Brien, supra note 
1, at 426 (discussing how a ban on antibiotics would lead to the elimination of 
the overcrowded conditions found on farms); Briceño, supra note 4, at 527 
(discussing how some animal producers consider antibiotic use a cheaper 
alternative than changing their animal facilities to provide healthier living 
conditions for the animals). 
 178. MATHEWS, supra note 4, at 7 (“[W]here livestock are concentrated, 
especially in hog and poultry feeding operations, diseases can spread rapidly, 
and disease outbreaks can take a far heavier toll if low levels of antimicrobial 
drugs are not fed.”); O’Brien, supra note 1, at 426 (“The closer the confinement 
[of the animals], the greater the chance that an infectious disease will afflict 
the herd.”). 
 179. See O’Brien, supra note 1, at 527. 
 180. See MATHEWS, supra note 4, at 7 (“Death losses and reduced 
production from diseases that had been prevented by feeding low levels of 
antimicrobial drugs could be costly.”); Centner, supra note 7, at 21 (discussing 
how there is concern that removal of antibiotics might lead to increased 
disease among animals). 
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animals.181 Because of all the changes that would likely be 
implemented on farms, consumers would have to pay more for 
animal products.182 
There also is concern that a complete ban on antibiotics 
would cause drug companies to cease developing new 
antibiotics.183 Opponents of a complete ban are concerned that 
drug companies would lose the incentive to develop new 
antibiotics because of the high cost of drug development.184 
With drawbacks to both the FDA’s current wait-and-see 
approach and a complete ban on antibiotics, the best solution is 
likely somewhere in the middle. 
E. BAN SOME ANTIBIOTICS AND MONITOR THE USE OF THE REST 
The FDA should pick a solution mid-way between their 
current wait-and-see approach and a complete ban on antibiotic 
use in animals. The United States should follow Europe’s 
precautionary approach185 and enact a ban on antibiotics that 
are also used in human health.186 This mid-way approach 
would allow farmers to continue to use antibiotics not used by 
humans. This approach would likely still require farmers to 
                                                          
 181. See MATHEWS, supra note 4, at 7 (discussing how a complete ban on 
antibiotic use in animals could lead to increased risk of animals getting sick; 
this is primarily due to the large concentration these farm animals live in). 
 182. See, e.g., Bjorn Lomborg, Food for the Wealthy, Not for the Poor, N.Y. 
TIMES (Sept. 11, 2012, 9:55 AM), http://www.nytimes.com/roomfordebate/
2012/09/10/is-organic-food-worth-the-expense/organic-food-is-for-the-wealthy-
not-the-poor (“Finally, organic entails a huge price tag. For the U.S. alone, 
estimates . . . suggest a cost of at least $100 billion annually.”). 
 183. Centner, supra note 7, at 28 (“Some have expressed concern that 
regulations restricting the use of antibiotics in animal production may reduce 
the incentives for pharmaceutical companies to develop new antibiotic 
drugs.”); Briceño, supra note 4, at 526 (discussing how drug companies are 
unlikely to develop new antibiotics if antibiotic resistance continues to be a 
problem). 
 184. Briceño, supra note 4, at 526. 
 185. See supra Part I.B.2. 
 186. It appears that this is the way the FDA is currently leaning. See 
Melinda Henneberger, Report: Feeding Antibiotics to Livestock Is Bad for 
Humans, But Congress Won’t Stop It, WASH. POST, Oct. 22, 2013, 
http://www.washingtonpost.com/politics/feeding-antibiotics-to-cows-is-bad-for-
humans-but-congress-wont-stop-it-new-report-says/2013/10/22/ecd2de08-3afd-
11e3-a94f-b58017bfee6c_story.html (“FDA guidelines in the pipeline . . . would 
require the industry to stop using antibiotics specifically to bulk up food 
animals but would continue to allow their use for disease control.”). 
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change their animal housing practices,187 and food costs would 
likely still rise,188 but it can be justified by considerations of 
human health. There also is evidence that some of the concerns 
farmers have about a complete antibiotic ban may not be 
true.189 In Finland, where nontherapeutic uses of antibiotics 
were banned, the rate of diseased pigs did not increase after 
the ban.190 Denmark had a similar result among its poultry 
after nontherapeutic antibiotics were banned.191 This mid-way 
resolution would also help decrease the pressure that the FDA 
is getting from both consumers and corporations. 
Pressure from consumers can lead food producers to 
voluntarily change their animal care techniques. If consumers 
are concerned about what chemicals they consume, they may 
change their eating habits. A way for consumers to change 
these habits is by purchasing organic products. Organic food 
products are increasing in popularity.192 To be a certified-
organic food product, the animals cannot be given antibiotics in 
their feed.193 The increasing popularity of organic food products 
demonstrates that people are concerned about what they are 
                                                          
 187. With farmers not being able to use all the currently-approved 
antibiotics, farmers would likely choose to lower the risk that their animals 
would get sick. See supra notes 176–78 (discussing how the crowded conditions 
that animals are kept in increases the risk that animals would get sick). If 
certain antibiotics were banned from animal use, however, farmers would not 
be without any option for treating their sick animals. See Centner, supra note 
7, at 25 (“Changes in the ingredients in feed, amount of feed, disinfection, 
stocking density, and vaccines may improve herd health and prevent 
[disease].”). 
 188. See, e.g., infra notes 191–98 and accompanying text (discussing the 
use of organic food products). 
 189. See Centner, supra note 7, at 25. 
 190. Id. (“In Finland, data suggest that swine producers did not experience 
any significant negative consequences after the withdrawal of non-therapeutic 
antibiotics.”). 
 191. Id. (“For Danish poultry production, the elimination of non-
therapeutic antibiotics has not negatively affected animal health . . . .”). But 
cf. id. at 24–25 (discussing how the elimination of nontherapeutic antibiotics 
had negative effects on Denmark’s pigs). 
 192. Mayo Clinic Staff, Organic Foods: Are They Safer? More Nutritious?, 
MAYO CLINIC (Sept. 7, 2012), http://www.mayoclinic.com/health/organic-
food/NU00255 (“Once found only in health food stores, organic food is now a 
regular feature at most supermarkets.”). 
 193. See id. (listing the differences between conventional and organic 
foods). 
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consuming.194 Companies like McDonald’s, Tyson Foods,195 and 
Bon Appétit196 have reacted to the increasing popularity of 
organic food by changing their corporate policies. McDonald’s 
has changed its poultry policy and will not use chicken that has 
been fed nontherapeutic antibiotics that are medically 
important to human health.197 Tyson Foods only uses poultry 
that has been “raised without antibiotics.”198 And Bon Appétit, 
a catering company, does not allow any nontherapeutic 
antibiotics to be used in their poultry.199 The FDA is also 
beginning to get pressure from the courts to follow through on 
its ban of certain antibiotics from animal use.200 All the 
pressure the FDA is receiving is because of the growing 
national concern over antibiotic resistance. 
Where human health is a concern, the FDA can take action 
to eliminate the risk.201 The FDA is not allowed to consider 
benefits of an animal drug when there is a human health 
concern.202 While the FDCA lists other factors that the FDA 
should consider when contemplating withdrawal of an animal 
                                                          
 194. See id. (listing reasons why some people choose organic food). Some 
people choose to buy organic food because the food additives that can be used 
in the food-producing animals are strictly regulated. Id. 
 195. Centner, supra note 7, at 23–24 (discussing actions that McDonald’s 
and Tyson Foods have taken). 
 196. Briceño, supra note 4, at 527 (discussing McDonald’s’ and Bon 
Appétit’s actions). 
 197. Centner, supra note 7, at 23; Briceño, supra note 4, at 527 
(“McDonald’s, one of the largest meat purchasers in the world, has 
implemented a purchasing policy by which it will only accept chicken that is 
raised without any medically-important antibiotics used for non-therapeutic 
purposes.”). 
 198. Centner, supra note 7, at 23. 
 199. Briceño, supra note 4, at 527 (“Bon Appétit, has an even stronger 
restriction [than McDonald’s]: they ban all use of non-therapeutic antibiotics 
in the poultry they purchase, not only medically important ones.”). 
 200. Natural Res. Def. Council, Inc. v. FDA, 884 F. Supp. 2d 127, 130 
(S.D.N.Y. 2012). The district court is requiring the FDA to initiate the 
withdrawal proceedings for the antibiotics at issue in the lawsuit. Id.; see also 
supra Part I.A. (discussing the most recent lawsuit against the FDA over the 
FDA’s inaction on withdrawing antibiotics from animal use). 
 201. See Halpern, supra note 19, at 425–26; Nelson, supra note 15, at 421 
(discussing how the possibility of potential health hazards is enough for the 
FDA to propose a ban of the antibiotic); Briceño, supra note 4, at 530 (“[T]he 
[Federal Food, Drug and Cosmetic Act] cites human health as one of the 
primary factors for FDA decision making, regardless of whether the drug is 
intended for humans or animals.”). 
 202. Briceño, supra note 4, at 531. 
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drug, the “overarching concern[ ]” is “human safety.”203 
Therefore, the FDA can withdraw approval of new animal 
drugs even without a direct link between antibiotic use in 
animals and antibiotic resistance in humans, as long as the 
FDA’s reason has to do with human health. The FDA can 
continue to monitor all the other antibiotics used in animal 
care that are not also used for human health. NARMS can 
remain in place to oversee the use of antibiotics and the spread 
of antibiotic resistance.204 
CONCLUSION 
Antibiotic resistance in humans is a health concern; it can 
lead to long, expensive hospital stays and an increased risk of 
death. Antibiotic use in animals has increased over the years, 
and it is now commonplace in the United States for farm 
animals to be fed low doses of antibiotics on a daily basis. 
Because of the high use of antibiotics in animals, the animals 
can develop antibiotic-resistant bacteria. The antibiotic-
resistant bacteria in farm animals can pass to humans through 
meat and poultry consumption, and therefore, antibiotic use in 
animals needs to be more stringently regulated. Currently, the 
FDA is working with the CDC and the USDA to monitor 
antibiotic use in animals and the spread of antibiotic resistance 
in humans. The FDA has decided to employ a wait-and-see 
approach and continues to perform research, through NARMS, 
to determine how big of a threat antibiotic use in animals 
actually is to humans. It seems the FDA is looking for a direct 
link before it acts. 
Antibiotic resistance is a major health concern that needs 
to be prevented. Because antibiotic resistance poses such a 
large threat to human health, the better solution is to act now 
before antibiotic resistance spreads even more. The FDA should 
coordinate its regulation efforts with domestic agencies (the 
USDA and the CDC) and international groups (the WHO and 
the EU). Then, the FDA should enact a ban on all antibiotics 
that are used in human health care. Finally, the FDA can 
continue to monitor the remaining antibiotics used in animals 
in order to determine whether these drugs also pose a threat to 
human health. 
                                                          
 203. Halpern, supra note 19, at 425. 
 204. See supra Part I.B.1. (discussing the current role of NARMS). 
